Saulesh Seitzhanovna Kurmangaliyeva

Saulesh Seitzhanovna Kurmangaliyeva

Auto-generated profile, based on publicly available information

Saulesh Seitzhanovna Kurmangaliyeva

Department of Microbiology, Virology and Immunology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2024 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
SKSaulesh Kurmangaliyeva
Saulesh Kurmangaliyeva
KBKristina Baktikulova
Kristina Baktikulova
VTViktoriya Tkachenko
Viktoriya Tkachenko
BSBibigul Seitkhanova
Bibigul Seitkhanova
NSNasriddin Shapambayev
Nasriddin Shapambayev
KKKairat Kurmangaliyev
Kairat Kurmangaliyev

1 January 2026 in Biochemistry Research International
Verified
Journal Article
Open access
KBKristina Baktikulova
Kristina Baktikulova
SKSaulesh Kurmangaliyeva
Saulesh Kurmangaliyeva
Amin TamadonAmin Tamadon
Amin Tamadon
KKKairat Kurmangaliyev
Kairat Kurmangaliyev
NMNadiar Maratovich Mussin
Nadiar Maratovich Mussin
RSRamazon Safarzoda Sharoffidin
Ramazon Safarzoda Sharoffidin
Introduction: Compensated cirrhosis carries a significant risk of progression to decompensation, which substantially worsens prognosis. Accurate prediction of decompensation events is critical for guiding surveillance, optimizing intervention timing, and improving patient outcomes. Although many prognostic biomarkers have been studied, findings remain heterogeneous. This umbrella review synthesizes evidence from systematic reviews and meta‐analyses to identify and appraise biomarkers predicting decompensation in alcoholic and nonalcoholic compensated cirrhosis. Methods: PubMed, Scopus, and Web of Science were searched to August 15, 2025, for English‐language systematic reviews and meta‐analyses. From the included meta‐analyses, prognostic performance, heterogeneity, and publication bias were recorded. Results: Four systematic reviews were included, two with meta‐analyses. Strong predictors across reviews were serum albumin, INR, bilirubin, platelet count, and liver stiffness measurement. HVPG remained a robust invasive predictor, while emerging biomarkers—interleukin‐6, keratin‐18, and extracellular vesicles—were associated with an increased risk of decompensation, although the certainty of evidence was limited by heterogeneity and methodological constraints. Composite scores enhanced predictive accuracy. AMSTAR 2 ratings ranged from high to low, with common reporting limitations. Overlap analysis indicated moderate redundancy among primary studies. Conclusions: Both established and emerging biomarkers predict decompensation in compensated cirrhosis. Integrated multidomain models combining clinical, biochemical, and imaging‐derived measures may provide the greatest predictive value for guiding clinical decision‐making.

10 January 2021 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
GKGulbakit K. Koshmaganbetova
Gulbakit K. Koshmaganbetova
SKSaulesh Kurmangalieva
Saulesh Kurmangalieva
YBYerlan Bazargaliyev
Yerlan Bazargaliyev
AZAzhar Zhexenova
Azhar Zhexenova
BUBaktybergen Urekeshov
Baktybergen Urekeshov
MAMadina Azhmuratova
Madina Azhmuratova
The purpose of this study was to determine whether the training module with a simulator of cardiology improves auscultation skills in medical students. Methods. Medical students of the third year after completing the module of the cardiovascular system of the discipline “Propaedeutics of internal diseases, passed a two-hour or four-hour training module in clinical auscultation with retesting immediately after the intervention and in the fourth year. The control group consisted of fourth-year medical students who had no intervention. Results. The diagnostic accuracy in two-hour training was 45.9% vs 35.3% in four-hour training p <.001. The use of a cardio simulator significantly increased the accurate detection of mitral regurgitation immediately after training on a simulator (more than 73%) p <.001. The next academic year, regression was observed in the diagnostic accuracy of mitral insufficiency in the intervention group after six months of observation by 4%. The auscultation skills of students at the bedside of real patients did not increase after training on a simulator: the accuracy of diagnosis of the auscultatory picture of the defect was equally low in the intervention group and the control group (35.0% vs 30.8%, p = 0.651). Conclusions. Two-hour training was more effective than four-hour training. After training on cardiac auscultation using a patient’s cardiological simulator, the accuracy rate was low in a situation close to the clinical conditions and a clinic on a real patient.

20 March 2025 in Journal of Environmental Treatment Techniques
Verified
Journal Article
Open access
PDF file
DKDiana Kunzharikova
Diana Kunzharikova
AKAkmeiir E. Kaliyeva
Akmeiir E. Kaliyeva
ABAkmaral Baspakova
Akmaral Baspakova
SKSaulesh S. Kurmangaliyeva
Saulesh S. Kurmangaliyeva
AAAizhan Alkaubayeva
Aizhan Alkaubayeva
Objectives patient satisfaction with the quality of laboratory services is a pivotal dimension in ensuring health care quality because it can affect the accuracy of diagnostic results, clinical decision-making, and overall trust in the health system. This review analyzes several critical factors that shape the perceptions of patients, including turnaround time, test accuracy, physician communication, easy access to services, and efficient delivery. The paper then considers trends such as automation, artificial intelligence, telemedicine and digital health integration, and how these new systems are affecting laboratory service quality and the patient experience. Additionally, this review explores mechanisms for quality improvement with a focus on accreditation and continuous quality management systems, ongoing professional education, and mechanisms to integrate patient feedback into systems level reform. Although substantial progress has been made, challenges, including workforce shortages, regulatory variability, and inequities in access to high-quality laboratory services, remain. Evidence-based interventions and patient-centered approaches are used to address these issues with the goal of improving service delivery and healthcare outcomes. This paper offers two important messages to those who influence and guide national policy, healthcare decisions, and development of clinical laboratories across the nation as we strive to change practice to meet new demand.

25 March 2025 in West Kazakhstan Medical Journal
Verified
Journal Article
Closed access
PDF file
SKSaulesh S. Kurmangaliyeva
Saulesh S. Kurmangaliyeva
AMAkzhan M. Madenbayeva
Akzhan M. Madenbayeva
SUSaltanat Urazayeva
Saltanat Urazayeva
KKKairat Kurmangaliyev
Kairat Kurmangaliyev
YBYerlan Bazargaliyev
Yerlan Bazargaliyev
GKGaukhar B. Kumar
Gaukhar B. Kumar
Long COVID-19 is characterized by the persistence of symptoms and immune alterations beyond the acute phase of SARS-CoV-2 infection. Understanding the demographic, clinical, and immunological differences between individuals with and without long COVID-19 is crucial for developing targeted interventions. This observational study included 206 participants, comprising 90 patients with long COVID-19 and 116 without. Data on demographic, lifestyle, and clinical characteristics were collected, alongside immune cell profiles and SARS-CoV-2 antibody levels. Statistical analyses compared these parameters between the two groups. Long COVID-19 patients were predominantly female (77.8%), older (47.78% aged 41–60, 20% >60 years), and had higher BMI, hypertension (31.1%), and autoimmune diseases (11.1%) compared to nonlong COVID-19 individuals (P < 0.001). Clinical symptoms unique to long COVID-19 included memory loss (40.0%), hair loss (37.8%), fatigue (35.6%), and myalgia/arthralgia (28.9%), all absent in the control group (P < 0.001). Immunologically, patients with long COVID-19 exhibited distinct immune profiles, including elevated cytotoxic T cells (CD3+CD8+), reduced B cells, and higher CD4/CD8 ratios. Moreover, long COVID-19 patients had higher SARS-CoV-2 antibody levels, with 15.5% showing levels between 1000–2500 BAU/ml, compared to 6.9% in controls. These immunological biomarkers, including altered T cell subsets and antibody levels, highlight the complex immune dysregulation associated with long COVID-19. These findings could inform future clinical management and therapeutic strategies targeting immune modulation.

20 December 2024 in West Kazakhstan Medical Journal
Verified
Journal Article
Closed access
PDF file
SKSaulesh S. Kurmangaliyeva
Saulesh S. Kurmangaliyeva
AMAkzhan M. Madenbayeva
Akzhan M. Madenbayeva
SUSaltanat Urazayeva
Saltanat Urazayeva
YBYerlan Bazargaliyev
Yerlan Bazargaliyev
KKKhatimya Kudabayeva
Khatimya Kudabayeva
KKKairat Kurmangaliyev
Kairat Kurmangaliyev
The COVID-19 pandemic has prompted an urgent need to understand the differences between vaccine-induced and natural immunity, particularly in the context of post- COVID syndrome (long COVID). This review compares the immune responses elicited by natural infection and vaccination, focusing on their duration, strength, and effectiveness in mitigating long COVID symptoms. Vaccine-induced immunity, primarily targeting the spike protein of SARS-CoV-2, often produces a more consistent antibody and T-cell response, especially when bolstered by booster doses. In contrast, natural immunity, though broader in scope, is more variable and influenced by factors such as infection severity. Hybrid immunity, resulting from both infection and vaccination, may offer superior protection against long COVID. This comparative analysis highlights the importance of understanding these immune mechanisms to optimize protection strategies against SARS-CoV-2 and its variants.